相似文献
1
Erratum: Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events.
Kidney Int Rep. 2021 May 20;6(7):1999-2007. doi: 10.1016/j.ekir.2021.05.016. eCollection 2021 Jul.
2
Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events.
Kidney Int Rep. 2020 Jul 27;5(10):1670-1678. doi: 10.1016/j.ekir.2020.07.027. eCollection 2020 Oct.
3
Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients.
Kidney Int Rep. 2021 Sep;6(9):2526-2531. doi: 10.1016/j.ekir.2021.07.022. Epub 2021 Sep 2.
4
Interdialytic weight gain correlates with glycosylated hemoglobin in diabetic hemodialysis patients.
Am J Kidney Dis. 1994 May;23(5):686-91. doi: 10.1016/s0272-6386(12)70279-2.
5
Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis.
Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1597-1605. doi: 10.2215/CJN.09050815. Epub 2016 Jun 23.
6
Erratum to "Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial." Kidney Int. Rep. 2020;5:2178-2182.
Kidney Int Rep. 2021 Mar 5;6(4):1196. doi: 10.1016/j.ekir.2021.02.021. eCollection 2021 Apr.
7
[Assessment of salt intake in hemodialysis].
Nefrologia. 2001 Jan-Feb;21(1):71-7.
8
Effect of oral sodium bicarbonate supplementation on interdialytic weight gain, plasma sodium concentrations and predialysis blood pressure in hemodialysis patients.
Blood Purif. 2005;23(5):379-83. doi: 10.1159/000087195. Epub 2005 May 27.
9
Interdialytic weight gain is less with the Mediterranean type of diet in hemodialysis patients.
J Ren Nutr. 2005 Oct;15(4):371-6. doi: 10.1053/j.jrn.2005.07.006.
10
Estimates of interdialytic sodium and water intake based on the balance principle: differences between nondiabetic and diabetic subjects on hemodialysis.
ASAIO J. 1998 Nov-Dec;44(6):812-7. doi: 10.1097/00002480-199811000-00009.
本文引用的文献
1
Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials.
Ren Fail. 2018 Nov;40(1):671-679. doi: 10.1080/0886022X.2018.1532909.
2
Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate.
Kidney Int Rep. 2017 Jan 5;2(3):359-365. doi: 10.1016/j.ekir.2016.12.005. eCollection 2017 May.
3
Revisiting Interdialytic Weight Gain and Mortality Association With Serum Albumin Interactions: The Japanese Dialysis Outcomes and Practice Pattern Study.
J Ren Nutr. 2017 Nov;27(6):421-429. doi: 10.1053/j.jrn.2017.05.003. Epub 2017 Jun 17.
4
Relationship between Hemoglobin Levels Corrected by Interdialytic Weight Gain and Mortality in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study.
PLoS One. 2017 Jan 3;12(1):e0169117. doi: 10.1371/journal.pone.0169117. eCollection 2017.
5
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.
JAMA Intern Med. 2016 Dec 1;176(12):1818-1825. doi: 10.1001/jamainternmed.2016.6520.
6
Improving clinical outcomes among hemodialysis patients: a proposal for a "volume first" approach from the chief medical officers of US dialysis providers.
Am J Kidney Dis. 2014 Nov;64(5):685-95. doi: 10.1053/j.ajkd.2014.07.003. Epub 2014 Aug 22.
7
Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients.
Ther Apher Dial. 2014 Oct;18(5):404-13. doi: 10.1111/1744-9987.12155. Epub 2014 Feb 25.
8
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement.
Nephrol Dial Transplant. 2013 Jun;28(6):1346-59. doi: 10.1093/ndt/gft033. Epub 2013 Apr 12.
9
Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients.
Nephrol Dial Transplant. 2012 Jun;27(6):2418-25. doi: 10.1093/ndt/gfr697. Epub 2011 Dec 20.
10
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.
Ann Intern Med. 2010 Jul 6;153(1):23-33. doi: 10.7326/0003-4819-153-1-201007060-00252. Epub 2010 Jun 24.
Zotero 插件